Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$4.03 - $7.57 $99,960 - $187,766
-24,804 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$5.29 - $9.1 $35,236 - $60,615
6,661 Added 36.71%
24,804 $189,000
Q2 2020

Aug 17, 2020

BUY
$4.25 - $8.46 $22,427 - $44,643
5,277 Added 41.02%
18,143 $153,000
Q1 2020

May 13, 2020

BUY
$4.06 - $11.0 $600 - $1,628
148 Added 1.16%
12,866 $64,000
Q1 2019

May 09, 2019

SELL
$7.93 - $10.41 $15,804 - $20,747
-1,993 Reduced 13.55%
12,718 $126,000
Q4 2018

Feb 13, 2019

BUY
$7.88 - $17.98 $115,922 - $264,503
14,711 New
14,711 $153,000

About LogicBio Therapeutics, Inc.


  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.